{
  "ticker": "LLY",
  "target_date": "2025-08-20",
  "actual_date": "2025-08-20",
  "collected_at": "2025-12-08T12:10:06.837038",
  "price": {
    "open": 700.49,
    "high": 704.76,
    "low": 684.15,
    "close": 704.405517578125,
    "volume": 4139400,
    "change_1d_pct": 0.32,
    "change_7d_pct": 11.3,
    "change_30d_pct": -10.16
  },
  "technicals": {
    "rsi_14": 43.64,
    "sma_20": 719.02,
    "sma_50": 757.35,
    "macd": -21.775,
    "macd_signal": -23.746,
    "macd_histogram": 1.97,
    "bb_upper": 839.29,
    "bb_lower": 598.75,
    "price_vs_sma20_pct": -2.03,
    "price_vs_sma50_pct": -6.99,
    "volume_ratio": 0.6
  },
  "fundamentals": {
    "market_cap": 892503392256,
    "pe_ratio": 48.779522,
    "forward_pe": 43.936012,
    "price_to_book": 37.484566,
    "price_to_sales": 15.020303,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.47,
    "pct_from_52w_low": 59.61
  },
  "macro": {
    "spy": {
      "price": 636.35,
      "change_1d_pct": -0.27,
      "change_7d_pct": -0.71
    },
    "vix": {
      "level": 15.69,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.3
    },
    "dollar_index": {
      "level": 98.22
    },
    "gold": {
      "price": 3343.4
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1755726539,
      "summary": "GMO\u00e2\u0080\u0099s 13F portfolio grew to $33.23B in Q2 2025, with Microsoft, Meta, Alphabet, Oracle, and Apple as top holdings. Read more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=1752da494c03f4d1c83d55ee99d4a662014fa49c4d61c67a181e3e504c898d52"
    },
    {
      "headline": "Navigating The Novo Nordisk Case With The Inversion Mental Model",
      "source": "SeekingAlpha",
      "datetime": 1755714574,
      "summary": "Discover potential risks for Novo Nordisk using Charlie Munger's inversion model. Explore market share, R&D, and why this stock may double in 5 years.",
      "url": "https://finnhub.io/api/news?id=64143f88b5434deb8778ecdecb3cf7ab3768b26445c6d6bed6cb5a8a500d4989"
    },
    {
      "headline": "Here's Why Viking Therapeutics Bounced Back Today",
      "source": "Yahoo",
      "datetime": 1755709156,
      "summary": "Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data were disappointing.",
      "url": "https://finnhub.io/api/news?id=e84f4e89aca20d838aae61131705be7a1a815e40be0acd1cf02dbc6ef7ae92d8"
    },
    {
      "headline": "Healthcare Stocks Are Trading at Their Biggest Discount in 30 Years. Why a Turnaround May Have Already Started.",
      "source": "Yahoo",
      "datetime": 1755708360,
      "summary": "Healthcare stocks have been in a funk.  For investors worried about elevated market valuations, they may be just what the doctor ordered.  The healthcare sector is enduring one of its worst patches on record, thanks to a slew of problems that include managed care costs and stiffening competition amo",
      "url": "https://finnhub.io/api/news?id=bac4cf0ea7881467ff9c515fc4e6f26afbd358afa325da4a85e56015ba45cbcb"
    },
    {
      "headline": "Viking Therapeutics' Stock Tanks on Mixed Data From Obesity Pill Study",
      "source": "Yahoo",
      "datetime": 1755704460,
      "summary": "VKTX shares plunge after mixed obesity pill study data shows weight loss success but high dropout rates.",
      "url": "https://finnhub.io/api/news?id=fb32903a50b2e1ac2ec92c80a8d8144412dad17f70345b8c210f5899ab76494e"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-08-20",
      "description": "d929636d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634987.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/xslF345X05/wk-form4_1755634987.xml"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634943.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000230/xslF345X05/wk-form4_1755634943.xml"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634883.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000228/xslF345X05/wk-form4_1755634883.xml"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634822.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000226/xslF345X05/wk-form4_1755634822.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}